Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report

• Główni autorzy: Yu-Chien Lin (Autor), Kuo-Chang Wen (Autor), Pi-Lin Sung (Autor), Yu-Ting Chou (Autor), Phui-Ly Liew (Autor), Lin-Yu Chen (Autor), Rui-Lan Huang (Autor), Hung-Cheng Lai (Autor), Lu-Te Chang (Autor)
• Format: Książka
• Wydane: BMC, 2020-12-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract Background Patients with ovarian clear cell carcinoma (OCCC) have a poor prognosis because they show low sensitivity to platinum-based chemotherapy. New treatments for refractory OCCC are urgently needed. Case presentation We present a patient with refractory OCCC in whom conventional chemo...